RNDr. Pavel Krejčí, Ph.D.
Head of the research group, Pavel Krejčí Research Group
Office: bldg. C03/246
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 5395 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 121
2015
-
Neutral Endopeptidase-Resistant C-Type Natriuretic Peptide Variant Represents a New Therapeutic Approach for Treatment of Fibroblast Growth Factor Receptor 3-Related Dwarfism
Journal of Pharmacology and Experimental Therapeutics, year: 2015, volume: 353, edition: 1, DOI
-
Nové terapeutické možnosti achondroplázie a založení registru pro malé lidi v ČR
Year: 2015, type: Conference abstract
-
Příprava Registru Achondroplázie REACH
Year: 2015, type: Conference abstract
-
Putting the brakes on chondrosarcoma
Oncotarget, year: 2015, volume: 6, edition: 28, DOI
2014
-
Effect of FGFR inhibitors on chicken limb development
Development Growth & Differentiation, year: 2014, volume: 56, edition: 8, DOI
-
FGF19/BETA-KLOTHO REGULATE PHYSIOLOGY AND DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELLS
Year: 2014, type: Conference abstract
-
Fibroblast Growth Factor Receptor 3 Interacts with and Activates TGFbeta-Activated Kinase 1 Tyrosine Phosphorylation and NFkappaB Signaling in Multiple Myeloma and Bladder Cancer
PLOS One, year: 2014, volume: 9, edition: 1, DOI
-
Phenotype-genotype correlations in patients with Marinesco-Sjogren syndrome
Clinical Genetics, year: 2014, volume: 86, edition: 1, DOI
-
TEC KINASE MODULATES AUTOCRINE/PARACRINE FGF2 SIGNALING IN HUMAN PLURIPOTENT STEM CELLS
Year: 2014, type: Conference abstract
-
The paradox of FGFR3 signaling in skeletal dysplasia: Why chondrocytes growth arrest while other cells over proliferate
Mutation Research - Reviews in Mutation Research, year: 2014, volume: 759, edition: January–March, DOI